First, I believe that for all cancers where it is used,
First, I believe that for all cancers where it is used, Keytruda only works in about 70-80% of those who quailify genetically.
I know that some Keytruda patients relapse because there is one living across the street from me. So maybe that is where the AE37 vaccine becomes useful - prevents relapse and possibly works for those 20-30% for whom it did not work initially. Just conjecturing.
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Vestis Corporation Announces Extension of Chief Legal Officer's Term Vestis Corporation (NYSE:VSTS), known for its wholesale distribution of nondurable goods, has recently announced an extension of Timothy Donovan’s tenure as Executive Vice President, Chief Legal Officer, and General Counsel. Originally slated for retirement on October 4, 2024, Donovan will now continue...
Continue Reading
Truist Financial Reports Strong Quarterly Performance Truist Financial (NYSE: TFC) has recently demonstrated remarkable financial strength, reporting profits that exceeded Wall Street expectations for the fourth quarter. This positive outcome can be attributed primarily to robust investment banking and enhanced trading activities, benefiting from a revitalization in...
Continue Reading
Innovations in Non-Interventional Research At the forefront of healthcare innovation, PicnicHealth showcases groundbreaking advancements in non-interventional research. The organization aims to simplify complex healthcare processes by leveraging artificial intelligence (AI). This approach not only minimizes the burden on pharmaceutical companies but also enhances the...
Continue Reading
Larry Fink, the Chief Executive Officer of BlackRock Inc. (BLK), weighed in on the market dynamics back in 2024, particularly around interest rate expectations from the Federal Reserve. He stirred the pot by stating that many traders were overestimating how aggressive these cuts would be. You know how it goes—when CEOs start tossing out warnings, desks start sweating....
Continue Reading
Introducing Apple's Upcoming Product Innovations Investors and enthusiasts of Apple Inc. (NASDAQ: AAPL) are buzzing with excitement over the potential product announcements on the horizon. While iPhone updates typically steal the spotlight, intriguing developments in other product lines are surging into focus. What to Expect from Apple's Upcoming Releases Recent expert...
Continue Reading
